Form 8-K Seres Therapeutics, Inc. For: Nov 27 – StreetInsider.com
Form 8-K Seres Therapeutics, Inc. For: Nov 27 StreetInsider.com … Continue reading →
Form 8-K Seres Therapeutics, Inc. For: Nov 27 – StreetInsider.com Read More »
Bitfarms Reports Financial Results for the Three and Nine Months Ended September 30, 2019 – Financial Post
Bitfarms Reports Financial Results for the Three and Nine Months Ended September 30, 2019 Financial Post … Continue reading →
Pure Acquisition Corp. Announces Business Combination Transaction – BOE Report
Pure Acquisition Corp. Announces Business Combination Transaction BOE Report … Continue reading →
Pure Acquisition Corp. Announces Business Combination Transaction – BOE Report Read More »
Pure Acquisition Corp. Announces Business Combination Transaction – GlobeNewswire
Pure Acquisition Corp. Announces Business Combination Transaction GlobeNewswire … Continue reading →
Pure Acquisition Corp. Announces Business Combination Transaction – GlobeNewswire Read More »
Oceanic Announces Conversion of Convertible Debentures and Settlement of Advance Royalty Payables – Canada NewsWire
Oceanic Announces Conversion of Convertible Debentures and Settlement of Advance Royalty Payables Canada NewsWire … Continue reading →
Oceanic Announces Conversion of Convertible Debentures and Settlement of Advance Royalty Payables – Yahoo Finance
Oceanic Announces Conversion of Convertible Debentures and Settlement of Advance Royalty Payables Yahoo Finance … Continue reading →
SLANG Worldwide Announces Q3 2019 Financial Results and Secures $15 Million Equity Financing – Canada NewsWire
SLANG Worldwide Announces Q3 2019 Financial Results and Secures $15 Million Equity Financing Canada NewsWire … Continue reading →
SLANG Worldwide Announces Q3 2019 Financial Results and Secures $15 Million Equity Financing – Yahoo Finance
SLANG Worldwide Announces Q3 2019 Financial Results and Secures $15 Million Equity Financing Yahoo Finance … Continue reading →
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants – Business Wire
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants Business Wire … Continue reading →
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants – Yahoo Finance
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants Yahoo Finance … Continue reading →